The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter

Trial Profile

The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs Brimonidine/timolol (Primary) ; Brimonidine; Timolol
  • Indications Glaucoma; Ocular hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Oct 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Oct 2015).
    • 13 Oct 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.
    • 13 Oct 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top